The latest quarterly R&D expense is $6.75 Million with a QoQ Growth of +9.51%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $6.75M.
$6.75M
$6.75 Million
Q2 FY2026 · 2026-06-30
+9.51%
vs. $6.16M prior quarter
14
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $6.75M | +9.51% | +39.06% |
| Q1 FY2026Period end 2026-03-31 | $6.16M | +21.71% | +45.10% |
| Q4 FY2025Period end 2025-12-31 | $5.06M | +1.59% | +29.36% |
| Q3 FY2025Period end 2025-09-30 | $4.98M | +2.70% | +46.77% |
| Q2 FY2025Period end 2025-06-30 | $4.85M | +14.27% | +55.16% |
| Q1 FY2025Period end 2025-03-31 | $4.25M | +8.51% | +35.79% |
| Q4 FY2024Period end 2024-12-31 | $3.91M | +15.26% | +45.57% |
| Q3 FY2024Period end 2024-09-30 | $3.40M | +8.57% | +47.10% |
| Q2 FY2024Period end 2024-06-30 | $3.13M | 0.00% | +56.39% |
| Q1 FY2024Period end 2024-03-31 | $3.13M | +16.33% | +56.39% |
| Q4 FY2023Period end 2023-12-31 | $2.69M | +16.46% | N/A |
| Q3 FY2023Period end 2023-09-30 | $2.31M | +15.43% | N/A |
| Q2 FY2023Period end 2023-06-30 | $2.00M | 0.00% | N/A |
| Q1 FY2023Period end 2023-03-31 | $2.00M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
